- Tekcapital said portfolio company Belluscura had reached an entire crowdfunding goal of £500k.

Tekcapital, which owned 25% of Belluscra, said it had a 'minority participation' in the current round.

Belluscura had developed a patented portable oxygen concentrator, which could deliver 96% pure oxygen to patients around the clock.

At 9:40am: [LON:TEK] Tekcapital share price was +1.25p at 13.5p

Story provided by